Inpatient versus other settings for detoxification for opioid dependence
- PMID: 15846721
- DOI: 10.1002/14651858.CD004580.pub2
Inpatient versus other settings for detoxification for opioid dependence
Abstract
Background: There are a complex range of variables that can influence the course and subjective severity of opioid withdrawal. There is a growing evidence for the effectiveness of a range of medically-supported detoxification strategies, but little attention has been paid to the influence of the setting in which the process takes place.
Objectives: To evaluate the effectiveness of any inpatient opioid detoxification programme when compared with all other time-limited detoxification programmes on the level of completion of detoxification, the intensity and duration of withdrawal symptoms, the nature and incidence of adverse effects, the level of engagement in further treatment post-detoxification, and the rates of relapse post-detoxification.
Search strategy: Electronic databases: the Cochrane Central Register of Controlled Trials (CENTRAL - The Cochrane Library Issue 3, 2004); MEDLINE (January 1966-March 2004); EMBASE (January 1988-March 2004); PsycInfo (January 1967-March 2004); CINAHL (January 1982-March 2004). In addition the Current Contents, Biological Abstracts, Science Citation Index and Social Sciences Index were searched.
Selection criteria: Randomised controlled clinical trials comparing inpatient opioid detoxification (any drug or psychosocial therapy) with other time-limited detoxification programmes (including residential units that are not staffed 24 hours per day, day-care facilities where the patient is not resident for 24 hours per day, and outpatient or ambulatory programmes, and using any drug or psychosocial therapy).
Data collection and analysis: All abstracts were independently inspected by two reviewers (ED & JI) and relevant papers were retrieved and assessed for methodological quality using Cochrane Reviewers' Handbook criteria.
Main results: Only one study met the inclusion criteria. This did not explicitly report the number of participants in each group that successfully completed the detoxification process, but the published data allowed us to deduce that 7 out of 10 (70%) in the inpatient detoxification group were opioid-free on discharge, compared with 11 out of 30 (37%) in the outpatient group. There was very limited data about the other outcomes of interest.
Authors' conclusions: This review demonstrates that there is no good available research to guide the clinician about the outcomes or cost-effectiveness of inpatient or outpatient approaches to opioid detoxification.
Similar articles
-
Methadone at tapered doses for the management of opioid withdrawal.Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003409. doi: 10.1002/14651858.CD003409.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003409. doi: 10.1002/14651858.CD003409.pub3. PMID: 15495052 Updated.
-
Pharmacological therapies for management of opium withdrawal.Cochrane Database Syst Rev. 2018 Jun 21;6(6):CD007522. doi: 10.1002/14651858.CD007522.pub2. Cochrane Database Syst Rev. 2018. PMID: 29929212 Free PMC article.
-
Eliciting adverse effects data from participants in clinical trials.Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2. Cochrane Database Syst Rev. 2018. PMID: 29372930 Free PMC article.
-
Methadone at tapered doses for the management of opioid withdrawal.Cochrane Database Syst Rev. 2003;(3):CD003409. doi: 10.1002/14651858.CD003409. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003409. doi: 10.1002/14651858.CD003409.pub2. PMID: 12917966 Updated.
-
Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification.Cochrane Database Syst Rev. 2004 Oct 18;(4):CD005031. doi: 10.1002/14651858.CD005031. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2008 Jul 16;(3):CD005031. doi: 10.1002/14651858.CD005031.pub2. PMID: 15495136 Updated.
Cited by
-
Changes in substance use during outpatient treatment for substance use disorders: a prospective Norwegian cohort study from 2016 to 2020.Subst Abuse Treat Prev Policy. 2021 Sep 15;16(1):67. doi: 10.1186/s13011-021-00403-9. Subst Abuse Treat Prev Policy. 2021. PMID: 34526054 Free PMC article.
-
Opioid antagonists with minimal sedation for opioid withdrawal.Cochrane Database Syst Rev. 2017 May 29;5(5):CD002021. doi: 10.1002/14651858.CD002021.pub4. Cochrane Database Syst Rev. 2017. PMID: 28553701 Free PMC article.
-
Detoxification treatments for opiate dependent adolescents.Cochrane Database Syst Rev. 2014 Apr 29;2014(4):CD006749. doi: 10.1002/14651858.CD006749.pub3. Cochrane Database Syst Rev. 2014. PMID: 24777492 Free PMC article.
-
Alpha₂-adrenergic agonists for the management of opioid withdrawal.Cochrane Database Syst Rev. 2016 May 3;2016(5):CD002024. doi: 10.1002/14651858.CD002024.pub5. Cochrane Database Syst Rev. 2016. PMID: 27140827 Free PMC article.
-
First-time admissions for opioid treatment: cross-sectional and descriptive study of new opioid users seeking treatment.Neuropsychiatr Dis Treat. 2015 Sep 24;11:2431-40. doi: 10.2147/NDT.S84431. eCollection 2015. Neuropsychiatr Dis Treat. 2015. PMID: 26445539 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous